Gayatri BioOrganics Limited carries a market capitalization of 523.11M, placing it among publicly traded companies globally. Its enterprise value stands at 1.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 523.11M |
| Enterprise Value | 1.46B |
Gayatri BioOrganics Limited currently has 78.79M shares outstanding.
| Shares Outstanding | 78.79M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 1.38 |
| P/TBV Ratio | -2.94 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | N/A |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 408.97 |
Gayatri BioOrganics Limited maintains a current ratio of 0.49, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -101.70, indicating conservative leverage, while an interest coverage ratio of -2.11 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.49 |
| Quick Ratio | 0.01 |
| Debt / Equity | -101.70 |
| Debt / EBITDA | -49.91 |
| Interest Coverage | -2.11 |
| Return on Equity (ROE) | -1.03 |
| Return on Assets (ROA) | -65.77 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Gayatri BioOrganics Limited's stock has gained approximately 3.38101% over the past 52 weeks. The 50-day moving average sits at 11.81, while the 200-day moving average is 13.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | 3.38101% |
| 50-Day Moving Average | 11.81 |
| 200-Day Moving Average | 13.30 |
| Average Volume (20 Days) | N/A |
EBITDA reached -7.54M, while operating income came in at -7.54M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -7.54M |
| Pretax Income | -11.12M |
| Net Income | -11.12M |
| EBITDA | -7.54M |
| EBIT | -7.54M |
| Earnings Per Share (EPS) | -0.14 |
Gayatri BioOrganics Limited holds 200,000.00 in cash and equivalents against 376.36M in total debt, resulting in a net debt position of 376.16M. Total book value stands at 787.88M, with working capital of -17.74M providing operational flexibility.
| Cash & Cash Equivalents | 200,000.00 |
| Total Debt | 376.36M |
| Net Debt | 376.16M |
| Equity (Book Value) | 787.88M |
| Book Value Per Share | 10.02 |
| Working Capital | -17.74M |
Gayatri BioOrganics Limited posts an Altman Z-Score of -1.00, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.00 |